London & Capital Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.1M | Buy |
126,158
+16,506
| +15% | +$6.69M | 3.88% | 7 |
|
|
2025
Q1 | $54.6M | Buy |
109,652
+41,131
| +60% | +$20.5M | 4.68% | 5 |
|
|
2024
Q4 | $35.6M | Buy |
68,521
+7,731
| +13% | +$4.02M | 3.04% | 5 |
|
|
2024
Q3 | $37.6M | Buy |
60,790
+2,196
| +4% | +$1.36M | 2.98% | 12 |
|
|
2024
Q2 | $32.4M | Sell |
58,594
-11,507
| -16% | -$6.36M | 2.74% | 14 |
|
|
2024
Q1 | $40.7M | Buy |
70,101
+393
| +0.6% | +$228K | 3.11% | 14 |
|
|
2023
Q4 | $37M | Buy |
69,708
+4,506
| +7% | +$2.39M | 3.1% | 14 |
|
|
2023
Q3 | $33M | Buy |
+65,202
| New | +$33M | 3.01% | 16 |
|